You're signed outSign in or to get full access.
Blue Owl Capital Holdings LP
Blue Owl Capital Holdings LP is a leading alternative asset management firm headquartered in New York, NY. Founded in 2021, it operates as part of Blue Owl Capital Inc., providing institutional and private wealth clients with a wide array of investment strategies across direct lending, GP stakes, real estate, and other alternatives. The firm serves global investors, including pension funds, endowments, and high-net-worth individuals, and has grown rapidly since inception to become one of the most significant alternative investment managers. Blue Owl employs more than 650 professionals worldwide.
Investment Strategy
Blue Owl Capital employs a multi-platform approach focused on providing capital and liquidity solutions primarily through direct lending to middle-market businesses, taking minority stakes in alternative asset management firms (GP stakes), and investing in real estate credit and equity opportunities. Their strategies emphasize stable, risk-adjusted returns, diversification, and long-term partnerships with clients. Blue Owl seeks to deliver consistent income-oriented results, leveraging specialized sector expertise and rigorous risk management.
Latest 13F Filing Activity
Blue Owl Capital Holdings LP filed their most recent 13F report on Jun 30, 2025 disclosing 56 equity positions with a total 13F market value of $310M. The fund increased holdings in Sagimet Biosciences Inc., Tempus Ai Inc., Larimar Therapeutics Inc. among other positions. Blue Owl Capital Holdings LP reduced exposure to Proshares TR, Holley Inc., Conduent Inc. among others.
Top Holdings
Equity Positions (56)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
N NCDL | NUVEEN CHURCHILL DIRECT LEND | 21.11% | $65.4M | 4,039,553 | $17.42 | $16.19 | -$3.2M |
O OBDC | BLUE OWL CAPITAL CORPORATION | 9.46% | $29.3M | 2,045,070 | $12.45 | $14.34 | -$654.4K |
C CGEM | CULLINAN THERAPEUTICS INC | 5.80% | $18.0M | 2,385,972 | $10.41 | $7.53 | -$473.9K |
E EVCM | EVERCOMMERCE INC | 5.56% | $17.2M | 1,641,929 | $9.17 | $10.50 | +$689.6K |
T TRML | TOURMALINE BIO INC | 5.15% | $15.9M | 997,107 | $23.90 | $15.99 | +$169.3K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more